Drugplain

Cold and Sinus Maxium Strength 650 mg/20mL

ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE · LIQUID · DeMoulas Market Basket

No Recall HistoryCurrently in Shortage
Plain English

Cold and Sinus Maxium Strength is a liquid containing acetaminophen, guaifenesin, phenylephrine hydrochloride at 650 mg/20mL, taken oral. Manufactured by DeMoulas Market Basket.

Key Facts

Brand Name
Cold and Sinus Maxium Strength
Generic Name
ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
NDC Code (Product)
53942-515
Manufacturer
DeMoulas Market Basket
Strength
650 mg/20mL
Dosage Form
LIQUID
Route
ORAL
Marketing Status
Application #
M012
Drug Class
Expectorant [EPC]
Marketing Start
09/19/2013

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

cardiac arrest1 reports
completed suicide1 reports
gastrointestinal disorder1 reports
hypertension1 reports
myalgia1 reports
respiratory arrest1 reports
urinary retention1 reports
vitamin b12 decreased1 reports

Frequently Asked Questions

What is Cold and Sinus Maxium Strength used for?

Cold and Sinus Maxium Strength contains ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE. It is a liquid taken oral. Consult your doctor for specific uses.

Is Cold and Sinus Maxium Strength a controlled substance?

Cold and Sinus Maxium Strength is not classified as a controlled substance by the DEA.

What is the generic name for Cold and Sinus Maxium Strength?

The generic name for Cold and Sinus Maxium Strength is ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE. There are 6 other brand versions of ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE.

What is the NDC code for Cold and Sinus Maxium Strength 650 mg/20mL?

The NDC (National Drug Code) for Cold and Sinus Maxium Strength 650 mg/20mL is 53942-515, listed by DeMoulas Market Basket.

Product NDC

53942-515

Package NDC

53942-515-25

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)